This is a routine procedural discovery ruling in a single-plaintiff employment case. No material financial exposure, no injunction, and no precedent risk. Monitor for any future dispositive motion or settlement announcement, but this ruling has no near-term trading relevance.
Price Chart
Executive Summary
A federal magistrate judge granted AstraZeneca's request to limit the temporal scope of a corporate deposition in a pending employment discrimination case (Title VII/ADEA) to 2021–2024, rejecting the plaintiff's bid to cover her full 20-year tenure. This is a routine discovery ruling in an individual employment case with no damages awarded, no injunction, and no material financial exposure stated — the case remains pending and the ruling has no immediate stock price impact.
Court Ruling Details
Key Facts
- Ruling is a discovery order on the temporal scope of a Rule 30(b)(6) deposition — not a final judgment or injunction
- No damages awarded, no damages pleaded amount stated in the opinion, no injunction issued
- Case is an individual employment discrimination suit (Title VII/ADEA) with no class allegations
- AstraZeneca's proposed 2021–2024 temporal limitation was granted with a caveat preserving plaintiff's right to explore pre-promotion conduct if defendant raises it at trial
- The opinion does not state any dollar amount in controversy or financial exposure for AstraZeneca
Financial Impact
No financial impact stated in the opinion — individual employment case with no damages figure or injunction
Risk Factors
- If the case proceeds to trial and plaintiff wins, potential damages could be material, but no amount is stated in this ruling
- No class certification or systemic liability — risk is confined to this individual case
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-ed21a00145-AZN |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $172.57 $171.49 | ▼ −0.63% | ▼ −0.10% | $171.43 (−0.66%) |
Oct 15, 2026 11d ago | Court Ruling | $165.41 $163.95 | ▼ −0.88% | ▼ −1.31% | $171.43 (+3.64%) |
Oct 5, 2026 21d ago | 6-K | $156.53 $158.61 | ▲ +1.33% | ▲ +0.78% | $171.43 (+9.52%) |
Oct 2, 2026 24d ago | 6-K | $156.90 $156.53 | ▼ −0.24% | ▼ −0.91% | $171.43 (+9.26%) |
Oct 2, 2026 24d ago | Court Ruling | $156.53 $158.61 | ▲ +1.33% | ▲ +0.78% | $171.43 (+9.52%) |
Oct 1, 2026 25d ago | 6-K | $157.70 $156.90 | ▼ −0.51% | ▼ −1.25% | $171.43 (+8.71%) |
Oct 1, 2026 25d ago | 6-K | $157.70 $156.90 | ▼ −0.51% | ▼ −1.25% | $171.43 (+8.71%) |
Sep 29, 2026 27d ago | 6-K | $164.21 $161.47 | ▼ −1.67% | ▼ −1.46% | $171.43 (+4.40%) |
Sep 23, 2026 4w ago | 6-K | $163.33 $164.56 | ▲ +0.75% | ▲ +0.84% | $171.43 (+4.96%) |
Sep 21, 2026 5w ago | 6-K | $168.10 $168.37 | ▲ +0.16% | ▲ +0.18% | $171.43 (+1.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers